Clinical Trial Update: OcuStem Nutritional Supplement in Diabetic Patients With Mild to Moderate Non-proliferative Retinopathy [NA]

View source ↗

Summary

Clinical trial update for the OcuStem nutritional supplement in diabetic patients with non-proliferative diabetic retinopathy; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• OcuStem Nutritional Supplement

Snippet

Sponsor: Aidan Products LLC | Conditions: Diabetic Retinopathy | NA | Status: UNKNOWN